NasdaqGM - Delayed Quote • USD
CareDx, Inc (CDNA)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
280,324.00
280,324.00
321,793.00
296,397.00
192,194.00
Cost of Revenue
101,999.00
101,999.00
112,212.00
97,389.00
63,117.00
Gross Profit
178,325.00
178,325.00
209,581.00
199,008.00
129,077.00
Operating Expense
283,068.00
283,068.00
286,812.00
228,734.00
146,792.00
Operating Income
-104,743.00
-104,743.00
-77,231.00
-29,726.00
-17,715.00
Net Non Operating Interest Income Expense
11,867.00
11,867.00
3,762.00
160.00
271.00
Other Income Expense
-97,267.00
-97,267.00
-2,765.00
-2,522.00
-2,306.00
Pretax Income
-190,143.00
-190,143.00
-76,234.00
-32,088.00
-19,750.00
Tax Provision
141.00
141.00
379.00
-1,426.00
-1,036.00
Net Income Common Stockholders
-190,284.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
Diluted NI Available to Com Stockholders
-190,284.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
Basic EPS
-1.69
-3.54
-1.44
-0.59
-0.40
Diluted EPS
-1.69
-3.54
-1.44
-0.59
-0.40
Basic Average Shares
53,800.25
53,764.71
53,321.63
52,241.08
46,481.77
Diluted Average Shares
53,800.25
53,764.71
53,321.63
52,241.08
46,481.77
Total Operating Income as Reported
-203,363.00
-203,363.00
-77,231.00
-29,726.00
-22,528.00
Total Expenses
385,067.00
385,067.00
399,024.00
326,123.00
209,909.00
Net Income from Continuing & Discontinued Operation
-190,284.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
Normalized Income
-112,382.10
-112,382.10
-76,697.53
-30,763.34
-17,296.74
Interest Income
11,867.00
11,867.00
3,762.00
160.00
271.00
Net Interest Income
11,867.00
11,867.00
3,762.00
160.00
271.00
EBIT
-104,743.00
-104,743.00
-77,231.00
-29,726.00
-17,715.00
EBITDA
-84,919.00
-84,919.00
-61,224.00
-17,841.00
-8,171.00
Reconciled Cost of Revenue
101,999.00
101,999.00
112,212.00
97,389.00
63,117.00
Reconciled Depreciation
19,824.00
19,824.00
16,007.00
11,885.00
9,544.00
Net Income from Continuing Operation Net Minority Interest
-190,284.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
Total Unusual Items Excluding Goodwill
-98,610.00
-98,610.00
107.00
106.00
-1,495.00
Total Unusual Items
-98,610.00
-98,610.00
107.00
106.00
-1,495.00
Normalized EBITDA
13,691.00
13,691.00
-61,331.00
-17,947.00
-6,676.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-20,708.10
-20,708.10
22.47
4.66
-77.74
12/31/2020 - 7/17/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VCYT Veracyte, Inc.
19.31
-0.87%
PSNL Personalis, Inc.
1.2650
+1.20%
MYGN Myriad Genetics, Inc.
18.18
+1.11%
TWST Twist Bioscience Corporation
31.54
+1.48%
NTRA Natera, Inc.
91.66
+0.42%
SHC Sotera Health Company
11.40
+0.71%
LAB Standard BioTools Inc.
2.4400
+3.39%
GH Guardant Health, Inc.
17.35
+1.11%
NEO NeoGenomics, Inc.
14.14
+2.09%
BDSX Biodesix, Inc.
1.2350
-1.98%